Unlock instant, AI-driven research and patent intelligence for your innovation.

Sulfonamide drug hapten and artificial antigen and preparation method and application thereof

A technology of sulfonamide drugs and artificial antigens, which is applied in the field of immunoassays, can solve the problems of few types of SAs, uneven cross-reaction rates, and poor sensitivity

Active Publication Date: 2020-06-23
北京明日达科技发展有限责任公司
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, more than 10 sulfonamide haptens including TS, SS, NS, SSS, HS, SA, BS, SA3, SA10, PS, SMX, SG and H1 have been synthesized, and corresponding broad-spectrum SAs polysaccharides have been prepared. Clonal and monoclonal antibodies, but these antibodies have the problems of recognizing few types of SAs, poor sensitivity, uneven cross-reactivity rate, etc., and cannot be well used for actual sample detection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Sulfonamide drug hapten and artificial antigen and preparation method and application thereof
  • Sulfonamide drug hapten and artificial antigen and preparation method and application thereof
  • Sulfonamide drug hapten and artificial antigen and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0071] Preparation and identification of embodiment 1 sulfa drug hapten

[0072] 1. Mix 100 g of ethyl 4-bromobutyrate (compound 1) and 150 g of triphenylphosphine, and reflux in 1 L of toluene for 24 hours. The precipitate was filtered, recovered, and washed with petroleum ether, and the operation was repeated 3 times. Drying in vacuo gave the product (compound 2) as a white solid.

[0073] 2. Dissolve 200g of 2,4-pentanedione (compound 3) and 200g of guanidine hydrochloride (compound 4) in 2L of water, and gradually add 550g of potassium carbonate. The reaction mixture was stirred at 40 °C for 24 h. The precipitate was filtered, washed with water, and repeated 3 times. Drying under vacuum afforded an off-white solid (Compound 5).

[0074] 3. Add 150 g of compound 5 and 200 g of N-bromosuccinimide into 1 L of acetonitrile, and heat at 80° C. for 6 h. The precipitate was filtered, washed with cold acetonitrile, and dried under vacuum to give a white solid (compound 6).

...

Embodiment 2

[0081] Example 2 Preparation of sulfa drugs immune antigen sulfamethazine valeric acid-hemocyanin

[0082] 1. Add 0.1mmol sulfamethazine valeric acid, 40mg N,N'-dicyclohexylcarbodiimide (DCC), 25mg N-hydroxysuccinimide (NHS) into 1mL DMF, stir overnight at room temperature to esterify (activate) the carboxyl group of the hapten.

[0083] 2. Take out the activated product and centrifuge at 4000rpm for 10min.

[0084] 3. Weigh 100mg of KLH and dissolve it in 20mL of pre-cooled PBS.

[0085]4. Take the centrifuged supernatant of the activated product, slowly add it dropwise to the KLH solution, and stir overnight at 4°C.

[0086] 5. Put the above reaction product in a dialysis bag, and dialyze overnight in 5L of dialysate.

[0087] 6. Take out the product, aliquot it and store it in a freezer at -70°C, that is, the immunogen sulfamethazine valeric acid-KLH. Example 3 Preparation of coated original sulfamethazine valeric acid-bovine serum albumin for detection of sulfa drugs

Embodiment 3

[0087] 6. Take out the product, aliquot it and store it in a freezer at -70°C, that is, the immunogen sulfamethazine valeric acid-KLH. Example 3 Preparation of coated original sulfamethazine valeric acid-bovine serum albumin for detection of sulfa drugs

[0088] 1. Take 0.5mmol sulfamethazine valeric acid, 200mg N,N'-dicyclohexylcarbodiimide (DCC), 100mg N-hydroxysuccinimide (NHS) and add it to 1mL DMF, stir overnight at room temperature to esterify (activate) the carboxyl group of the hapten.

[0089] 2. Take out the activated product and centrifuge at 4000rpm for 10min.

[0090] 3. Weigh 500mg of BSA and dissolve it in 20mL of pre-cooled PBS.

[0091] 4. Take the centrifuged supernatant from the activated product, slowly add it dropwise to the BSA solution, and stir overnight at 4°C.

[0092] 5. Put the above reaction product in a dialysis bag, dialyze for three days, and change the dialysate every 8 hours.

[0093] 6. Take out the product, subpackage it and store it in a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a sulfonamide hapten, a sulfonamide artificial antigen and their preparation methods and application. The sulfonamide hapten has a structure shown as formula (1) which is shown in the description, wherein n is an integer equal to 0, or greater than and equal to 1. The sulfonamide artificial antigen is made by coupling the hapten of the formula (1) and a carrier protein. Byimmunizing animals with the sulfonamide artificial antigen, specific antibodies with high efficacy and high sensitivity can be attained. The sulfonamide hapten and antibodies prepared with the same help provide a new means to establish a method to detect sulfonamides under high speed, good simplicity, low cost, good sensitivity and good specificity.

Description

technical field [0001] The invention relates to the field of immune detection, in particular to sulfonamide drug haptens and artificial antigens and their preparation methods and applications. Background technique [0002] Sulfonamides (SAs) have the advantages of broad antibacterial spectrum, low price, stable chemical properties and convenient use, and are still widely used in veterinary clinics, animal husbandry and aquaculture to prevent and treat bacterial infectious diseases. However, unreasonable use or even abuse can easily cause SAs to remain in animal tissues, and then accumulate in the human body through the food chain and other channels, endangering human health. At present, China, the European Union, the United States, Japan and other countries or regions have stipulated the maximum residue limits (MRLs) of sulfa drugs in animal foods. In addition to controlling the irrational use of SAs from the source, the detection and monitoring of drug residues in animal-d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D239/42C07K14/765C07K14/77C07K14/795C07K16/44G01N33/68G01N33/577G01N33/53
Inventor 王战辉沈建忠温凯李成龙柯跃斌张素霞史为民
Owner 北京明日达科技发展有限责任公司